NICE backs combination inhalers for chronic asthma

Combination inhalers have been approved for patients with chronic asthma in the latest guidance from NICE.

For adults and children over 12 years who require both an inhaled corticosteroid (ICS) and a long-acting beta-2 agonist (LABA), a combination device should be considered to deliver the drugs.

The guidance recommends GPs choose between combination treatment and separate devices, depending on the likelihood of adherence to the treatment and therapeutic need. Combination inhalers can be a cheaper option than separate inhalers too, said NICE.

Current evidence, supported by the British Thoracic Society, suggests that if a patient's asthma is poorly controlled using ICS, adding a LABA is more effective than increasing the ICS dose.

tom.ireland@haymarket.com

Nice Guidance

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus